The evidence for exercise-induced inflammation in intermittent claudication: Should we encourage patients to stop walking?

European Journal of Vascular and Endovascular Surgery

Volumn 15, Issue 1, 1998, Pages 7-17

  Tisi, P V ^a   Shearman, C P ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Acute phase proteins; Exercise; Intermittent claudication; Ischaemia reperfusion

Indexed keywords

ACUTE PHASE PROTEIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; FREE RADICAL; SERUM AMYLOID A;

ATHEROGENESIS; HUMAN; INFLAMMATION; INTERMITTENT CLAUDICATION; LEUKOCYTE ACTIVATION; MEDICAL LITERATURE; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; VASCULAR ENDOTHELIUM; WALKING;

EID: 0031910135     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5884(98)80066-X     Document Type: Review

References (122)

1. Housley E Treating claudication in five words Br Med J 296 1988 1483 1484
2. Housley E Leng GC Donnan PT Fowkes FG Physical activity and risk of peripheral arterial disease in the general population: Edinburgh Artery Study J Epidemiol Community Health 47 1993 475 480
3. Powell E Pratt M Physical activity and health Br Med J 313 1996 126 127
4. Secretary of State for Health The Health of the Nation. A strategy for health in England 1992 HMSO 46 47
5. Secretary of State for Health The Health of the Nation. A strategy for health in England 1992 HMSO London 62 64
6. Ernst E Exercise: the best therapy for intermittent claudication? Br J Hosp Med 48 1992 303 307
7. Larsen OA Lassen NA Effect of daily muscular exercise in patients with intermittent claudication Lancet ii 1966 1093 1095
8. Ericsson B Haeger K Lindell SE Effect of physical training on intermittent claudication Angiology 21 1970 188 192
9. Dahllof AG Bjorntorp P Holm J Schersten T Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency Eur J Clin Invest 4 1974 9 15
10. Dahllof AG Holm J Peripheral arterial insufficiency. Effect of physical training on walking tolerance, calf blood flow and blood resistance Scand J Rehab Med 8 1976 19 26
11. Hiatt WR Regensteiner J Hargarten ME Wolfen EE Benefit of exercise conditioning for patients with peripheral arterial disease Circulation 81 1990 602 609
12. Gardner AW Poehlman ET Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis JAMA 274 1995 975 980
13. Creasy TS McMillan PJ Fletcher EWL Collin J Morris PJ Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial Eur J Vasc Surg 4 1990 135 140
14. Perkins JMT Collin J Creasy TS Fletcher EWL Morris PJ Exercise training versus angioplasty for stable claudication: long and medium term results of a prospective randomised trial Eur J Vasc Endovasc Surg 11 1996 409 413
15. Dormandy JA Mahir M Ascady G Balsano F De Leeuw P Fate of the patient with chronic leg ischaemia J Cardiovasc Surg 30 1989 50 57
16. Bainton D Sweetnam P Baker I Elwood P Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study Br Heart J 72 1994 128 132
17. Holm J The effect of exercise on intermittent claudication Bell PRF Jamieson CW Ruckley CV Surgical Management of Vascular Diseases 1992 Saunders London 111 118
18. Haimovici H Muscular, renal and metabolic complications of acute arterial occlusions: myonephropathic-metabolic syndrome Surgery 85 1979 461 468
19. Parks DA Granger DN Contributions of ischemia and reperfusion to mucosal lesion formation Am J Physiol 250 1986 G749 G753
20. Caillard P Mouren X Pujade B Blanchemaison P Elbeze Y Cloarec M Objectifying exercise ischaemia in peripheral vascular disease: a study in 120 patients Angiology 12 1990 469 478
21. McCord JM Ocygen-derived free radicals in postischemic tissue injury N Engl J Med 312 1985 159 163
22. Windsor ACJ Mullen PG Fowler AA Sugerman HJ Role of the neutrophil in adult respiratory distress syndrome Br J Surg 80 1993 10 17
23. Lelcuk S Alexander F Valeri R Shepro D Hechtman H Thromboxane A2 moderates permeability after limb ischaemia Ann Surg 202 1985 642 646
24. Homer-Vanniasinkam S Gough MJ Role of lipid mediators in the pathogenesis of skeletal muscle infarction and oedema during reperfusion after ischaemia Br J Surg 81 1994 1500 1503
25. Sinclair AJ Barnett AH Lunec J Free radicals and antioxidant systems in health and disease Br J Hosp Med 43 1990 341 344
26. Parks DA Bulkley GB Granger DN Role of oxygen free radicals in shock, ischemia and organ preservation Surgery 94 1983 428 438
27. Paterson IS Klausner JM Goldman G Pulmonary edema after aneurysm surgery is modified by mannitol Ann Surg 210 1989 796 801
28. Paterson IS Corson J McCollum CN Goldman MD Middleton MD Activated neutrophils mediate multiple organ dysfunction following aortic aneurysm repair Br J Surg 76 1992 358
29. Paterson IS Smith FCT Tsang GMK Hamer JD Shearman CP Reperfusion plasma contains a neutrophil activator Ann Vasc Surg 7 1993 68 75
30. Hickmam P McCollum PT Belch JJF Neutrophils may contribute to the morbidity and mortality of claudicants Br J Surg 81 1994 790 798
31. Klausner JM Paterson IS Mannick JA Valeri CR Shepro D Hechtman HB Reperfusion pulmonary edema JAMA 261 1989 1030 1035
32. Bengtson A Holmberg P Heideman M The ischaemic leg as a source of complement activation Br J Surg 74 1987 697 700
33. Neumann FJ Waas W Diehm C Activation and decreased deformability of neutrophils after intermittent claudication Circulation 82 3 1990 922 929
34. Baggiolini M Walz A Kunkel SL Neutrophil activating peptide-1/Interleukin 8, a novel cytokine that activates neutrophils J Clin Invest 84 1989 1045 1049
35. Gross V Andreesen R Leser HG Ceska M Interleukin-8 and neutrophil activation in acute pancreatitis Eur J Clin Invest 22 1992 200 203
36. Furchgott RF Zawadzki JV The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetycholine Nature 288 1980 373 376
37. Palmer RMJ Ferrige AG Moncada S Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526
38. Vallance P Collier J Biology and clinical relevance of nitric oxide Br Med J 309 1994 453 459
39. Davies MG Fulton GJ Hagen PO Clinical biology of nitric oxide Br J Surg 82 1995 1598 1610
40. Weight SC Bell PRF Nicholson ML Renal ischaemia-reperfusion injury Br J Surg 83 1996 162 170
41. Grace P Ischemia-reperfusion injury Br J Surg 81 1994 637 647
42. Vane JR Anggard EE Botting RM Regulatory functions of the vascular endothelium N Eng J Med 323 1990 27 36
43. Haynes WG Webb DJ The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin Sci 84 1993 485 500
44. Edwards JD Dovgan PS Rowley JM Agrawal DK Thorpe PE Adrian TE Endothelin-1 levels in ischaemia, reperfusion and haemorrhagic shock in the canine infrarenal aortic revascularization model Eur J Vasc Surg 8 1994 729 734
45. Hickman P Harrison DK Hill A Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage Adv Exp Med Biol 36 1994 P565 P570
46. Hickman P McClaren M Hill H McCollum PR Belch JJ Exercise causes endothelial damage in claudicants but in healthy controls Br J Surg 81 1994 616
47. Shearman CP Gosling P Gwynn BR Simms MH Systemic effects associated with intermittent claudication. A model to study biochemical aspects of vascular disease? Eur J Vasc Surg 2 1988 401 404
48. Stringer MD Gorog PG Freeman A Kakkar VV Lipid peroxides and athersclerosis Br Med J 298 1989 281 284
49. Edwards AT Blann AD Suarez-Mendez VJ Systemic responses in patients with intermittent claudication after treadmill exercise Br J Surg 81 1994 1738 1741
50. Khaira HS Maxwell SRJ Shearman CP Antioxidant consumption during exercise in intermittent claudication Br J Surg 82 1995 1660 1662
51. Crinnion JN Homer-Vanniasinkam S Parkin SM Gough MJ The role of neutrophil-endothelial adhesion in skeletal muscle reperfusion injury Br J Surg 83 1996 251 254
52. Hickey NC Gosling P Baar S Shearman CP Simms MH Effect of surgery on the systemic inflammatory response to intermittent claudication Br J Surg 77 1990 1121 1124
53. Khaira HS Nash GB Bahra PS Thromboxane and neutrophil changes following intermittent claudication suggest ischaemia-reperfusion injury Eur J Vasc Endovasc Surg 10 1995 31 35
54. Wennmalm A Edlund A Sevastik B Fitzgerald A Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication Clin Physiol 8 1988 243 252
55. Jellinek H Detre Z Role of the altered transmural permeability in the pathomechanism of arteriosclerosis. Part I. History of arteriosclerosis theories Path Res Pract 181 1986 693 712
56. Winocour PH Microalbuminuria Br Med J 304 1992 1196 1197
57. Shearman CP Gosling P Simms MH Glomerular permeability to large molecules: a marker of vascular permeability? Br J Surg 75 1988 1273
58. Kannel WB Stampfer MJ Castelli WP Verter J The prognostic significance of proteinuria: the Framingham study Am Heart J 108 1984 1347 1352
59. (Suppl.) Gosling P Shearman CP Increased levels of urinary proteins: markers of vascular permeability? Ann Clin Biochem 25 1988 S150 S151
60. Gosling P Beevers DG Goode GE Hickey NC Littler WA Shearman CP Lancet 335 1990 349 350
61. Watts GF Bennett JE Rowe DJ Assessment of immunochemical methods for determining low concentrations of albumin in urine Clin Chem 32 1986 1544 1548
62. Shearman CP Gosling P Walker KJ Is low proteinuria an early predictor of severity of acute pancreatitis? J Clin Pathol 42 1989 1132 1135
63. Gosling P Shearman CP Gwynn BR Simms MH Bainbridge ET Microproteinuria: response to operation Br J Med 296 1988 338 339
64. Gosling P Beevers DG Urinary albumin excretion and blood pressure in the general population Clin Sci 76 1989 39 42
65. Smith FCT Gosling P Sanghera K Green MA Paterson IS Shearman CP Microproteinuria predicts the severity of systemic effects of reperfusion injury following infrarenal aortic aneurysm surgery Ann Vasc Surg 8 1994 1 5
66. Hickey NC Shearman CP Gosling P Simms MH Assessment of intermittent claudication of exercise-induced microalbuminuria Eur J Vasc Surg 4 1990 603 606
67. Matsushita M Nishikimi N Sakurai T Yano T Nimura Y Urinary microalbumin as a marker for intermittent claudication Eur J Vasc Endovasc Surg 11 1996 421 424
68. Tsang GM Sanghera K Gosling P Pharmacological reduction of the systemically damaging effects of local ischaemia Eur J Vasc Surg 8 1994 205 208
69. Blann AD von Willebrand factor as a marker of injury to the endothelium in inflammatory vascular disease J Rheumatol 20 1993 1469 1471
70. Blann AD McCollum CN von Willebrand factor, endothelial cell damage and atherosclerosis Eur J Vasc Surg 8 1994 10 15
71. Blann AD McCollum CN Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis Thromb Haemost 72 1994 151 154
72. Blann AD Dobrotova M Kubisz P McCollum CN von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis Thromb Haemost 74 1995 626 630
73. Ross R The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
74. Ernst EE Hammerschmidt DE Bagge U Matrai A Dormandy JA Leukocytes and the risk of ischaemic diseases JAMA 257 1987 2318 2324
75. Leake DS Oxidised low density lipoproteins and atherogenesis Br Heart J 69 1993 476 478
76. Witzum JL The oxidation hypothesis of atherosclerosis Lancet 344 1994 793 795
77. Witzum JL Steinberg D Role of oxidised low density lipoprotein in atherogenesis J Clin Invest 88 1991 1785 1792
78. Liao F Andalibi A Lusis AJ Fogelman AM Gentic control of the inflammatory response induced by oxidised lipids Am J Cardiol 75 1995 65B 66B
79. Gown AM Tsukada T Ross R Human atherosclerosis. II. Immunocytochemical analysis of the cellular compositon of human atherosclerotic lesions Am J Path 125 1986 191 207
80. Ross R The pathogenesis of atherosclerosis — an update N Engl J Med 314 1986 488 500
81. Mitchinson MJ Ball RY Macrophages and atherogenesis Lancet 2 1987 146 148
82. Heinrich PC Castell JV Andus T Interleukin-6 and the acute phase response Biochem J 265 1990 621 636
83. Clin Exp 3: 115–129 Stuart J The acute-phase reaction and haematological stress syndrome in vascular disease Int J Microcirc 1984
84. Khaw KT Woodhouse P Interrelation of vitamin C, infection, haemostatic factors and cardiovascular disease Br J Med 310 1995 1559 1562
85. Kannel WB Wolf PA Castelli WP D'Agostino RB Fibrinogen and risk of cardiovascular disease. The Framingham Study JAMA 258 1987 1183 1186
86. Meade TW Brozovic M Chakrabarti RR Haines AP Imeson JD Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study Lancet 2 1986 533 537
87. Yarnell JWG Baker IA Sweetnam PM Bainton D Fibrinogen, viscosity and white blood cell count are major risk factors for ischaemic heart disease Circulation 83 1991 836 844
88. Fowkes FG Fibrinogen and peripheral arterial disease Eur Heart J 16 Suppl. A 1995 36 40
89. Lee AJ Fowkes FGR Rattray A Rumley A Lowe GDO Haemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease Br J Haem 92 1996 226 230
90. Lowe GD Fowkes FG Dawes J Donnan PT Lennie SE Housley E Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study Circulation 87 1993 1915 1920
91. Dormandy JA Hoare E Khattab AH Arrowsmith DE Dormandy TL Prognostic significance of rheological and biochemical findings in patients with intermittent claudication Br Med J 4 1973 581 583
92. Hamer JD Ashton F Meynell MJ Factors influencing prognosis in the surgery of peripheral vascular disease: platelet adhesiveness, plasma fibrinogen and fibrinolysis Br J Surg 60 1973 386 389
93. Banerjee AK Pearson J Gilliland EL A six-year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants Thromb Haemost 68 1992 261 263
94. Smith EB Keen GA Grant A Stirk C Fate of fibrinogen in human arterial intima Arteriosclerosis 10 1990 263 275
95. Heinrich J Schulte H Schonfeld R Kohler E Assman G Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain Thromb Haemost 73 1995 374 379
96. Hamsten A De Faire U Iselius L Blombao M Genetic and cultural inheritance of plasma fibrinogen concentration Lancet 2 1987 988 990
97. Fowkes FGR Connor JM Smith FB Wood J Donnan PT Lowe GDO Fibrinogen genotype and risk of peripheral atherosclerosis Lancet 339 1992 693 696
98. Machin SJ Mackie IJ Routine measurement of fibrinogen concentration Br Med J 307 1993 882 883
99. Cruikshank AM Fraser WD Burns HJG Van Damme J Shenkin A Response of serum interleukin-6 in patients undergoing elective surgery of varying severity Clin Sci 79 1990 161 165
100. Pepys MB Rheumatoid arthritis: the role of acute-phase proteins Br J Rheumatol 32 Suppl. 3 1993 1 2
101. Kushner I Gewurz H Benson MD C-reactive protein and the acute-phase response J Lab Clin Med 97 1981 739 749
102. Pepys MB Baltz ML Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein Adv Immunol 34 1983 141 212
103. Majewski W Zielinski A Laciak M C-reactive protein and alpha-1-acid glycoprotein in monitoring of patients with chronic arterial occlusion of the lower limbs Eur J Vasc Surg 7 1993 623 628
104. Wilkins J Gallimore JR Tennent GA Rapid automated enzyme immunoassay of serum amyloid A Clin Chem 40 1994 1284 1290
105. Mendall MA Patel P Strachan D Northfield TC C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study Br Med J 312 1996 1061 1065
106. Tisi PV Crow AJ Shearman CP The use of inflammatory markers in the assessment of intermittent claudication Eur Surg Res 28 Suppl. 1 1996 65
107. Maseri A Biasucci LM Liuzzo G Inflammation in ischaemic heart disease Br Med J 312 1996 1049 1050
108. Thompson SG Kienast J Pyke SDM Haverkate F Van De Loo JCW Haemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris N Engl J Med 332 1995 635 641
109. Liuzzo G Biasucci LM Gallimore JR The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina N Engl J Med 331 1994 417 424
110. Maury CPJ Comparative study of serum amyloid A protein and C-reactive protein in disease Clin Sci 68 1985 233 238
111. Liao F Andalibi A Qiao JH Allayee H Fogelman AM Lusis AJ Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction and aortic fatty streak formation in mice J Clin Invest 94 1994 877 884
112. Malle E Steinmetz A Raynes JG Serum amyloid A (SAA): an acute phase protein and apolipoprotein Atherosclerosis 102 1993 131 146
113. Raynes JG Eagling S McAdam KP Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobulin by interleukin-1 and interleukin-6 Clin Exp Immunol 83 1991 488 491
114. Urieli-Shoval S Meek RL Hanson RH Eriksen N Benditt EP Human serum amyloid A genes are expressed in monocyte/macrophage cell lines Am J Pathol 145 1994 650 660
115. Meek RL Urieli-Shoval S Benditt EP Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function Proc Natl Acad Sci U.S.A. 91 1994 3186 3190
116. Gordon DJ Rifkind BM High-density lipoprotein — the clinical implications of recent studies N Engl J Med 321 1998 1311 1316
117. Blackburn WDJ Validity of acute phase proteins as markers of disease activity J Rheumatol Supp 42 1994 9 13
118. Kisilevsky R Subrahmanyan L Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function Lab Invest 66 1992 778 785
119. Xu L Badolato R Murphy WJ A novel biologic function of serum amyloid A. Induction of T-lymphocyte migration and adhesion J Immunol 155 1995 1184 1190
120. Badolato R Wang JM Murphy WJ Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes J Exp Med 180 1994 203 209
121. Maury CPJ Totterman KJ Gref CG Ehnholm C Serum amyloid A protein, apolipoprotein A-I and apolipoprotein B during the course of acute myocardial infarction J Clin Path 41 1988 1263 1268
122. Tisi PV Hulse M Chulakadabba A Gosling P Shearman CP Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg 14 1997 344 350